Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytosolic iron-sulfur assembly component 2A (CIAO2A) is a protein involved in the assembly and incorporation of iron-sulfur (Fe-S) clusters into target cytosolic and nuclear proteins via the cytosolic iron-sulfur protein assembly (CIA) complex. It is predicted to enable metal ion binding activity, contributes to protein maturation by Fe-S cluster transfer, and localizes to the cytosol and nucleoplasm. CIAO2A is classified as a non-enzymatic, non-receptor, non-transporter protein, and is not considered a primary therapeutic target[1][2][5][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytosolic iron-sulfur assembly component 2A (CIAO2A).